Gold nanoparticle conjugation enhances the antiacanthamoebic effects of chlorhexidine by Aqeel, Yousuf et al.
Gold Nanoparticle Conjugation Enhances the Antiacanthamoebic
Effects of Chlorhexidine
Yousuf Aqeel,a Ruqaiyyah Siddiqui,b Ayaz Anwar,c Muhammad Raza Shah,c Naveed Ahmed Khanb
Department of Molecular and Cell Biology, School of Medicine, Boston University, Boston, Massachusetts, USAa; Department of Biological Sciences, Faculty of Science and
Technology, Sunway University, Bandar Sunway, Malaysiab; International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry, University of
Karachi, Karachi, Pakistanc
Acanthamoeba keratitis is a serious infection with blinding consequences and often associated with contact lens wear. Early di-
agnosis, followed by aggressive topical application of drugs, is a prerequisite in successful treatment, but even then prognosis
remains poor. Several drugs have shown promise, including chlorhexidine gluconate; however, host cell toxicity at physiologi-
cally relevant concentrations remains a challenge. Nanoparticles, subcolloidal structures ranging in size from 10 to 100 nm, are
effective drug carriers for enhancing drug potency. The overall aim of the present study was to determine whether conjugation
with gold nanoparticles enhances the antiacanthamoebic potential of chlorhexidine. Gold-conjugated chlorhexidine nanopar-
ticles were synthesized. Briefly, gold solution was mixed with chlorhexidine and reduced by adding sodium borohydride, result-
ing in an intense deep red color, indicative of colloidal gold-conjugated chlorhexidine nanoparticles. The synthesis was con-
firmed using UV-visible spectrophotometry that shows a plasmon resonance peak of 500 to 550 nm, indicative of gold
nanoparticles. Further characterization using matrix-assisted laser desorption ionization-mass spectrometry showed a gold-
conjugated chlorhexidine complex atm/z 699 ranging in size from 20 to 100 nm, as determined using atomic force microscopy.
To determine the amoebicidal and amoebistatic effects, amoebae were incubated with gold-conjugated chlorhexidine nanopar-
ticles. For controls, amoebae also were incubated with gold and silver nanoparticles alone, chlorhexidine alone, neomycin-con-
jugated nanoparticles, and neomycin alone. The findings showed that gold-conjugated chlorhexidine nanoparticles exhibited
significant amoebicidal and amoebistatic effects at 5M. Amoebicidal effects were observed by parasite viability testing using a
Trypan blue exclusion assay and flow-cytometric analysis using propidium iodide, while amoebistatic effects were observed us-
ing growth assays. In contrast, chlorhexidine alone, at a similar concentration, showed limited effects. Notably, neomycin alone
or conjugated with nanoparticles did not show amoebicidal or amoebistatic effects. Pretreatment of A. castellaniiwith gold-
conjugated chlorhexidine nanoparticles reduced amoeba-mediated host cell cytotoxicity from 90% to 40% at 5M. In contrast,
chlorhexidine alone, at similar concentrations, had no protective effects for the host cells. Similarly, amoebae treated with neo-
mycin alone or neomycin-conjugated nanoparticles showed no protective effects. Overall, these findings suggest that gold-conju-
gated chlorhexidine nanoparticles hold promise in the improved treatment of A. castellanii keratitis.
Acanthamoeba is a free-living opportunistic pathogen that hasgained significant clinical attention over the past few years. It
is a causative agent of fatal granulomatous amoebic encephalitis in
immunocompromised individuals and causes a sight-threatening
keratitis in contact lens wearers (1–3). The treatment includes the
use of a combination of drugs, including chlorhexidine diglu-
conate, neomycin, propamidine isethionate, 5-fluorocytosine,
polyhexamethylene biguanide, and pentamidine isethionate (3–
5). However, these drugsmay exhibit side effects at recommended
concentrations. For example, mature cataracts and iris atrophy
developed in Acanthamoeba keratitis patients due to the use of
0.02% chlorhexidine and 0.01% propamidine isethionate (6).
Similarly, 5-fluorocytosine and pentamidine isethionate caused
hematologic damage and nephrotoxicity in immunocompro-
mised patients with amoebic infections (7, 8). Among various
drugs, chlorhexidine digluconate is themost commonly used drug
in the treatment of Acanthamoeba keratitis. Chlorhexidine is a
polybiguanide compound, commonly present in the form of salts
such as chlorhexidine digluconate. It is an antiseptic agent used in
mouthwashes, as a skin cleanser in surgical scrubs, and in germi-
cidal hand washes. It acts by releasing a positive chlorhexidine
cation under physiological pH that reacts with the negatively
charged plasma membrane, resulting in membrane structure and
permeability changes that cause ionic leakage, cytoplasmic dis-
ruption, and, ultimately, cell death. It is readily used in the treat-
ment of Acanthamoeba keratitis at a concentration of 0.02%,
which exhibits both trophicidal and cysticidal effects (9).
Nanoparticles are subcolloidal structures ranging in size from
10 to 100 nm and are effective drug carriers for enhancing drug
potency. By controlling the structure precisely at nanoscale di-
mensions, their surface structure is modified, which can help in
the improved bioavailability of poorly absorbed drugs and enable
them to be delivered efficiently. Antimicrobial formulation in the
form of nanoparticles is shown to act as an effective bactericidal
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material against Gram-positive and Gram-negative bacteria (10–
12). Gold (Au) nanoparticles with well-developed surface chem-
istry, controllable geometry, and chemical stability are excellent
tools to be used in biological studies. The overall aimof the present
study was to determine whether conjugation with gold nanopar-
ticles can enhance the antiacanthamoebic effects of chlorhexidine
digluconate.
MATERIALS AND METHODS
Acanthamoeba castellanii cultures. All chemicals were purchased from
Sigma (Poole, Dorset, England), unless otherwise stated. Chlorhexidine
digluconate (282227) (99%purity) and neomycin trisulfate salt hydrate
(N6386) (95% purity) were used in the present study. A keratitis isolate
of A. castellanii belonging to the T4 genotype was purchased from the
American Type Culture Collection (ATCC 50492). Amoebae were rou-
tinely grown in 10 ml PYG medium (0.75% [wt/vol] proteose peptone,
0.75% [wt/vol] yeast extract, 1.5% [wt/vol] glucose) in T75 75-cm2 tissue
culture flasks at 30°C (13). The medium was changed 18 h before the
experiment, and amoebae adherent to the flask, representing the tropho-
zoite form, were collected by placing it on ice for 20 min with gentle
agitation and used in all experiments.
HBMECcultures.The brainmicrovascular cells were of humanorigin
and cultured as described previously (14, 15). The endothelial cells were
purified using fluorescent-activated cell sorting (FACS), and their purity
was checked by the expression of endothelial markers such as F-VIII and
carbonic anhydrase IV and the uptake of acetylated low-density lipopro-
tein (Dil-AcLDL), resulting in more than 99% pure endothelial cultures.
The human brain microvascular endothelial cells (HBMEC) were rou-
tinely grown in rat tail collagen-coated tissue culture dishes in RPMI 1640
containing 10% heat-inactivated fetal bovine serum, 10% Nu-Serum, 2
mM glutamine, 1 mMNa-pyruvate, 100 U penicillin/ml, 100 g strepto-
mycin/ml, nonessential amino acids (glycine, L-alanine, L-asparagine, L-
aspartic acid, L-glutamic acid, L-proline, and L-serine), and vitamins (cho-
line chloride, D-calcium pantothenate, folic acid, nicotinamide,
pyridoxal hydrochloride, riboflavin, thiamine hydrochloride, and I-
inositol) and incubated at 37°C in a 5% CO2 incubator. For cytotoxicity
assays, HBMEC (106 cells/ml/well) were incubated for 24 h until the con-
fluent monolayers were formed and used in all subsequent experiment.
Synthesis of nanoparticles. Initially, gold (Au) and silver (Ag) were
selected as metallic carrier due to their inert nature in biological systems
and synthesized at a stock concentration of 10mM. In order to synthesize
Au-conjugated chlorhexidine nanoparticles, 5 ml (1 mM) of gold(III)
chloride trihydrate solution was added to 5 ml (1 mM) of chlorhexidine
solution, and the mixture was placed on a shaker. After 10 min, 30 l (10
mM) aqueous sodium borohydride was added as a reducing agent. The
intense deep red color, characteristic of colloidal gold nanoparticles, was
obtained instantly on its addition. The solution was placed on a stirrer for
an additional 2 h. After this, UV-visible spectrophotometry, atomic force
microscopy, and matrix-assisted laser desorption-mass spectrometry
(MALDI-MS) were performed for the characterization of Au-conjugated
chlorhexidine nanoparticles. For Ag-conjugated neomycin, 10ml (1mM)
silver nitrate aqueous solution was added to 2 ml (1 mM) of neomycin
solution, and themixture was placed on a shaker. After 10min, 0.5ml (30
mM) of sodium borohydride was added as a reducing agent and shaking
was continued for another 6 h, after which the solution was subjected to
characterization using UV-visible spectrophotometry, atomic force mi-
croscopy, and MALDI-MS. To determine whether Ag-conjugated chlo-
rhexidine and Au-conjugated neomycin exhibit increased efficacy, at-
tempts were made to conjugate Au with neomycin and Ag with
chlorhexidine as described above. Conversely, bare Au and Ag nanopar-
ticles were prepared by reducing it with 30 l (10 mM) aqueous sodium
borohydride just before use.
ESI-MS of nanoparticles. In order to quantify the amount of drug
used for conjugation with nanoparticles, electrospray ionization mass
spectrometry (ESI-MS) was performed. ESI is also known as soft ioniza-
tion. High voltage is applied to the liquidmedium, which creates aerosols.
The ions produced then are passed through the mass spectrometry chan-
nel through which mass spectrum is obtained. Briefly, the colloidal solu-
tion was collected in a 1.5-mlmicrocentrifuge tube and centrifuged at full
speed to ensure the complete settlement of nanoparticles. The centrifuged
material was separated and 0.1% trifluoroacetic acidwas added. After this,
the sample was injected for mass spectrometry analysis using an Agilent
6460 ESI-MS that was run in positive mode.
Atomic forcemicroscopy of nanoparticles. In order to determine the
morphology of nanoparticles, atomic force microscopic analysis was per-
formed as described previously but with slightmodifications (13). Briefly,
a cover glass of 18-mm diameter was rinsed in distilled water, followed by
threewashes in 70%ethanol. After this, 10l of Au-conjugated chlorhexi-
dine andAg-conjugated neomycin synthesized previously was overlaid on
the surface of the coverslip in the biosafety hood at room temperature and
incubated until it was dried. The following day, images were obtained
using an Agilent 5500 atomic force microscope operated in tappingmode
by using a siliconnitride soft cantilever of triangular shape (modelMLCT-
AUHW; Veeco) having a normal spring of 0.01N per m and 0.1N per m.
Amoebicidal assays. To determine the effects of Au-conjugated chlo-
rhexidine nanoparticles on amoebae, cidal assays were performed as de-
scribed previously (16). Briefly, A. castellanii (106 amoebae/0.5 ml/well)
was incubated with 1 M, 2.5 M, 5 M, 7.5 M, 10 M, and 20 M
concentrations of Au-conjugated chlorhexidine nanoparticles and chlo-
rhexidine alone. Additionally, amoebae were incubated with RPMI alone,
20 MAg-conjugated neomycin, neomycin alone, Ag nanoparticles, and
Au nanoparticles for 24 h at 37°C in 24-well plates. After this incubation,
plates were incubated on ice for 20 min, scraped using a rubber police-
man, and centrifuged in BD Falcon round-bottom polystyrene tubes at
1,500  g for 10 min. The pellet was resuspended in 25 mg/liter pro-
pidium iodide and incubated for 10 min. Five hundred microliters of
phosphate-buffered saline (PBS) was added, and flow-cytometric analysis
was performed using a FACSAria III fluorescence-activated cell sorter
system (Becton Dickinson, Heidelberg, Germany). The illumination of
propidium iodidewas recorded using filter 585/42 as previously described
(17). The dot plots on the graph were gated for phycoerythrin (PE-A) on
the horizontal axis and side scattering (SSCeH) on the vertical axis, treated
amoebae were superimposed onto analysis gates and compared to con-
trols, and the percent viability was determined on the basis of at least
10,000 events after treatment.
Growth inhibition assays. To determine the effects of Au-conjugated
chlorhexidine nanoparticles on the growth of A. castellanii, assays were
performed as described previously (18). Briefly, A. castellanii (5  105
amoebae/0.5 ml/well) organisms were incubated with various concentra-
tions of Au-conjugated chlorhexidine nanoparticles at 37°C for 48 h. After
this incubation, the number of amoebae were determined using hemocy-
tometer counting. For controls, amoebae were incubated in solvent alone,
chlorhexidine alone, Ag-conjugated neomycin nanoparticles, and neo-
mycin alone.
Host cell cytotoxicity. To determine antiamoebic effects of Au-con-
jugated chlorhexidine nanoparticles in vitro, assays were performed using
HBMEC. A. castellanii (5  105 amoebae/0.5 ml/well) organisms were
pretreated with various concentrations of Au-conjugated chlorhexidine
nanoparticles and chlorhexidine alone. Amoebae also were incubated
with 20MAg andAu nanoparticles, neomycin, and Ag-conjugated neo-
mycin nanoparticles for 24 h. Amoebae next were collected by centrifu-
gation at 1,000 g for 5min. The supernatants were aspirated and pellets
resuspended in 0.5 ml of RPMI 1640. This process was repeated 3 to
remove any residual drugs. Finally, amoebae were inoculated onHBMEC
monolayers grown in 24-well plates. Plates were incubated at 37°C in a 5%
CO2 incubator for 18 h. The next day, cell-free conditioned medium was
collected and host cell cytotoxicity was determined by measuring lactate
dehydrogenase (LDH) release using a cytotoxicity detection kit (Roche,
Indianapolis, IN). The HBMEC incubated alone were used as a negative
control, whereas monolayers lysed with 1% Triton X-100 for 30 min at
Aqeel et al.
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37°C were used to represent 100% cell death. The absorbance of samples
was converted to percent cytotoxicity using the following equation: (sam-
ple value  cells alone)/(total cell death  cells alone)  100  percent
cytotoxicity.
RESULTS
Synthesis of gold-conjugated chlorhexidine and silver-con-
jugated neomycin was confirmed using UV-visible spectro-
photometry, atomic force microscopy, and MALDI-MS. To
determine Au-conjugated chlorhexidine and Ag-conjugated neo-
mycin synthesis, UV visible spectrophotometry, MALDI-MS, and
atomic forcemicroscopywere performed. Au-conjugated chlorhexi-
dine andAg-conjugated neomycin nanoparticles showedUV-visible
characteristic surface plasmon resonance bands around 500 to 550
nm and 400 to 500 nm. A comparative UV spectral analysis of
Au-conjugated chlorhexidine, Ag-conjugated neomycin, and
drug alone is shown (Fig. 1A and B). A drastic enhancement in the
absorbance intensity and a small shift in maximum absorbance
wavelength (max) suggest that chlorhexidine and neomycin were
successfully capped on the Au and Ag surfaces. Further, to quan-
tify the drug, mass spectrometric analysis was done, and it was
observed that at this optimized ratio between metal and drug, the
entire drug was attached to the metal surface. Sample preparation
for ESI-MS analysis showed no peaks for molecular weights of
drugs at 505 m/z for chlorhexidine and 614 m/z for neomycin.
Hence, we concluded from this observation that the complete
drug is attached to the metal surface and no free drug is present in
the colloids (see the figure in the supplemental material). Finally,
atomic force microscopy was performed to determine the mor-
phology of particles and their size distribution. Au-conjugated
chlorhexidine nanoparticles were found to be spherical and poly-
disperse in size, ranging from 20 to 100 nm (Fig. 2A). Ag-conju-
gated neomycin nanoparticles were found to lie in a much nar-
rower size distribution, ranging from 2 to 20 nm (Fig. 2B).
Notably, attempts to conjugate Au with neomycin or Ag with
chlorhexidine were unsuccessful (data not shown).
Gold-conjugated chlorhexidine nanoparticles exhibited amoe-
bicidal effects. To determine the effects of Au-conjugated chlo-
rhexidine nanoparticles and chlorhexidine alone on the viability
of A. castellanii, amoebicidal assays were performed. The results
revealed that Au-conjugated chlorhexidine nanoparticles exhib-
ited significant amoebicidal effects against A. castellanii to 40% at
5M (P 0.05 using 2-sample t test and two-tailed distribution)
(Fig. 3). Similarly, amoebae treated with chlorhexidine alone ex-
hibited cidal effects, and the number of amoebae was reduced to
60% at 5 M (P  0.05 using 2-sample t test and two-tailed dis-
tribution) (Fig. 3). In controls, silver-conjugated neomycin nano-
particles and neomycin alone exhibited no effects against A. cas-
tellanii (Fig. 3). Conversely, treatment with bare gold and silver
nanoparticles alone had no observable adverse effects on amoebae
(Fig. 3).
Gold-conjugated chlorhexidine nanoparticles inhibited
growth of A. castellanii. To determine the effects of Au-conju-
gated chlorhexidine nanoparticles on the growth of A. castellanii,
assays were performed in the presence of growth medium, i.e.,
PYG. Au-conjugated chlorhexidine nanoparticles showed inhibi-
tory effects on amoeba growth at 5 M, and the numbers were
significantly reduced (P  0.05 using 2-sample t test and two-
tailed distribution) (Fig. 4). In contrast, amoebae treated with
chlorhexidine alone did not exhibit growth-inhibitory effects at 5
M (P  0.05 using 2-sample t test and two-tailed distribution)
(Fig. 4). Controls (amoebae incubated with solvent and bare
nanoparticles) showed no inhibitory effects on amoeba growth,
and the numbers were doubled after 24 h. Similarly, amoebae
incubated with Ag-conjugated neomycin nanoparticles and
neomycin alone showed no inhibitory effects on amoeba
growth (Fig. 4).
Gold-conjugated chlorhexidine inhibited A. castellanii-me-
diated host cell cytotoxicity. A. castellanii cells were pretreated
with Au-conjugated chlorhexidine nanoparticles for 24 h in
RPMI, followed by host cell cytotoxicity assays. In the absence of
any drug, A. castellanii produced 90%HBMEC death within 18 h.
Pretreatment of A. castellanii with Au-conjugated chlorhexidine
nanoparticles significantly reduced host cell cytotoxicity to 40% at
5M (P 0.05 using 2-sample t test and two-tailed distribution)
(Fig. 5). In contrast, pretreatment of A. castellanii with chlorhexi-
dine did not exhibit significant protective effects at 5 M (P 
0.05 using 2-sample t test and two-tailed distribution). Similarly,
amoebae treatedwithAg-conjugated neomycin nanoparticles and
FIG 1 Representative UV-visible spectrophotometry of gold (Au)-conjugated
chlorhexidine and silver (Ag)-conjugated neomycin showed a surface plasmon
resonance band at 500 to 550 nm and 400 to 500 nm. (A) UV-visible spectro-
photometry of Au-conjugated chlorhexidine showed a plasmon resonance
band at 500 to 550 nm indicative of Au nanoparticles. Conversely, Au alone
also showed a band in same region but with lower intensity. Chlorhexidine
alone showed a band at around 200 to 250 nm. (B)UV-visible spectrophotom-
etry of Ag-conjugated neomycin showed a plasmon resonance band at around
400 to 450 nm, indicating the synthesis of Ag-conjugated neomycin nanopar-
ticles. Simultaneously, Ag alone also showed a plasmon band at 400 to 450 nm.
Furthermore, neomycin alone did not absorb well in the UV spectrum and
produced a band of very low intensity at around 250 nm.
Au-Chlorhexidine Nanoparticle against Acanthamoeba
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neomycin alone did not show any protective effects for HBMEC
against A. castellanii (Fig. 5).
DISCUSSION
Among different carriers developed for improved drug delivery,
such as liposomes, carbon nanotubes, dendrimers, polymeric mi-
celles, polymeric conjugates, and nanoparticles, only a few have
reached clinical applications. It is hoped that drug carriers not
only transport the chemotherapeutic agents but also protect drugs
from degradation. In particular, the applications of nanoparticles
in biomedical research, fromdiagnostics to therapeutics, in recent
years have increased exponentially. Given their small size, high
reactivity, as well as translocation into living cells, stability in
harsh conditions such as high temperatures offers promise in clin-
ical settings. The most widely used nanoparticles include gold,
silver, titaniumoxide, and ironnanoparticles (19). As gold is inert,
it exhibits weak cytotoxic effects; thus, it is considered the nano-
particle of choice when performing conjugations with various
biomolecules and ligands to develop strategies for targeting
pathogens (20–22). Cytotoxic drugs can be encapsulated or phys-
ically entrapped within a nanosphere or entrapped into a cavity
surrounded by nanocapsules (23). Previous studies have devel-
oped antimicrobial formulations in the form of nanoparticles that
exhibit effective bactericidal effects against Gram-positive and
Gram-negative bacteria (10–12). Here, we determined whether
conjugation with gold-conjugated nanoparticles enhances the an-
tiacanthamoebic effects of chlorhexidine digluconate. Au-conju-
gated chlorhexidine and Ag-conjugated neomycin were success-
fully synthesized that exhibited well-developed surface chemistry,
controllable geometry, and chemical stability as determined by
UV-visible spectrophotometry, MALDI-MS, and atomic force
microscopy.
Amoebicidal assays revealed that although both Au-conju-
gated chlorhexidine and chlorhexidine alone exhibited amoebi-
cidal properties, Au-conjugated chlorhexidine showed higher lev-
els of toxicity against A. castellanii than chlorhexidine alone, 60%
FIG 2 Au-conjugated chlorhexidine ranges in size from 20 to 100 nm, and Ag-conjugated neomycin nanoparticles have sizes from 2 to 20 nm. The particle size
varies from 20 to 100 nm. Atomic force microscopy was performed as described in Materials and Methods. Briefly, cover glasses were overlaid with Au-
conjugated chlorhexidine and Ag-conjugated neomycin and air dried. On the following day, images were obtained using an Agilent 5500 atomic force micro-
scope. Au-conjugated chlorhexidine nanoparticles were spherical and polydisperse in size within the range of 20 to 100 nm (A), while Ag-conjugated neomycin
nanoparticles had a narrower size distribution, ranging from 2 to 20 nm (B). The results are representative of several experiments.
Aqeel et al.
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versus 40%, respectively. The increased cytotoxicity likely is due to
the high reactivity of nanoparticles with living cells as well as easy
translocation of drug into the living cells, enhancing drug efficacy
(24). Chlorhexidine is a positively charged molecule that binds to
the negatively charged sites on the cell membrane and destabilizes
the cellular integrity, resulting in leakage and, finally, cell death.
Enhanced effects of Au-conjugated chlorhexidine also may be ex-
plained by the fact that, in addition to chlorhexidine effects on
parasite membranes, metals such as Ag or Au affect DNA replica-
tion ability and the expression of ribosomal subunit proteins and
enzymes involved in ATP production or enzymes involved in the
respiratory chain (11); however, the precise mechanism of en-
hanced amoebicidal effects of Au-conjugated chlorhexidine still is
not well understood. It is also possible that nanoparticles of Au-
conjugated chlorhexidine are taken up (via phagocytosis) and/or
retained more effectively than with chlorhexidine alone. Another
likely explanation is that Au conjugation allows interaction with
thiols, providing an effective and selective means of controlled
intracellular release to affect amoeba viability. Au nanoparticles
alone or Ag-conjugated neomycin had no effects, suggesting that
cytotoxic effects are due to chlorhexidine. Chlorhexidine conju-
gated with gold at 5 M showed significantly higher growth-
inhibitory effects than chlorhexidine alone. When PYG is the
medium, it is reasonable to suggest that nanoparticles of Au-
conjugated chlorhexidine are taken up and/or retained better (via
phagocytosis) than chlorhexidine alone (25, 26), which may ex-
plain the increased recovery of chlorhexidine-treated amoebae af-
ter 48 h of incubation.
Pretreatment of amoebae with 5 M Au-conjugated chlo-
rhexidine, but not chlorhexidine alone, protected host cells
against A. castellanii-mediated cytotoxicity. Of note, 7.5 M Au-
conjugated chlorhexidine also exhibited levels of protection sim-
ilar to those seen for 5 M. When chlorhexidine alone was used
(Fig. 5), there was no difference between 5 M and 7.5 M (P
0.05). However, when we compared data to those for the control
(no drug), a significant difference was observed only with 7.5 M
and not 5 M. When Au-conjugated chlorhexidine was studied
(Fig. 5), again there was no difference between 5 M and 7.5 M
FIG 3 A. castellanii cell death was observed by treatment with Au-conjugated
chlorhexidine nanoparticles, determined by flow cytometry by propidium io-
dide staining as described inMaterials andMethods. FACS scattergram results
are expressed as percent viable A. castellanii. Note that Au-conjugated chlo-
rhexidine nanoparticles and chlorhexidine alone exhibited significant anti-
acanthamoebic effects at concentrations of 5 M or higher (P  0.05 using
2-sample t test with two-tailed distribution). The results are expressed as the
means 	 standard errors from three independent experiments performed in
duplicate.
FIG 4 Au-conjugated chlorhexidine nanoparticles and chlorhexidine alone
exhibited amoebistatic effects. Briefly, A. castellanii (5 105 amoebae) organ-
isms were incubated with various concentrations of Au-conjugated chlorhexi-
dine nanoparticles and chlorhexidine alone for 48 h at 37°C as described in
Materials and Methods. The next day, amoeba counts were determined by
hemocytometer counting. Note that Au-conjugated chlorhexidine nanopar-
ticles at 5 M concentration, but not chlorhexidine alone at 5 M concentra-
tion, exhibited significant inhibitory effects on A. castellanii growth compared
to that of amoebae incubated in solvent alone (P 0.05 using 2-sample t test
with two-tailed distribution). The dotted bar indicates the original inoculum.
The results are expressed as the means	 standard errors from three indepen-
dent experiments performed in duplicate.
FIG 5 Treatment with Au-conjugated chlorhexidine nanoparticles abolished
A. castellanii-mediatedHBMEC cytotoxicity. Briefly, amoebae (5 105 amoe-
bae/0.5 ml/well) were incubated with different concentrations of Au-conju-
gated chlorhexidine nanoparticles and chlorhexidine alone for 24 h in RPMI
and then incubated with HBMEC for 18 h at 37°C in a 5% CO2 incubator as
described in Materials and Methods. The next day, cell-free supernatant was
collected and cytotoxicity was determined. The results revealed that pretreat-
ment with Au-conjugated chlorhexidine nanoparticles at 5Mconcentration,
but not chlorhexidine alone at 5 M concentration, abolished A. castellanii-
mediatedHBMEC cytotoxicity. The results are expressed as themeans	 stan-
dard errors from three independent experiments performed in duplicate.
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(P  0.05). However, when we compared data to those for the
control (no drug), significant difference was observed at both 5
M and 7.5 M. This was consistent with amoebicidal findings
reported in Fig. 3. Based on these data, we conclude that the con-
jugation of chlorhexidine with nanoparticles enhances their anti-
amoebic efficacy, as we are able to see differences in protection
against host cell cytotoxicity at lower concentrations of the drug.
Although in vivo studies are needed to further assess their effi-
cacy, these findings confirm that nanoparticles are promising car-
riers in enhancing chemotherapeutic effects of the present drugs.
They provide enhanced stability, tuneable surface conjugation
chemistry, monodisperse size distribution, physicochemical
properties, higher drug loading, controlled drug release, im-
proved pharmacokinetics, and dual effects of drug agent and
nanoparticles, which suggests that nanotechnology together
with available antiamoebic compounds will offer effective and
less toxic options to patients for the treatment of Acanthamoeba
infections.
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